SYMAP MEDICAL
SyMap is dedicated to developing a proprietary, catheter-based renal mapping and ablation system for renal denervation therapy to treat hypertension and other diseases, such as heart failure, arrhythmia, and renal failure.
SYMAP MEDICAL
Industry:
Biotechnology Health Care Medical Device
Founded:
2012-08-10
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.symapmedical.com
Total Employee:
51+
Status:
Active
Total Funding:
110.05 M USD
Similar Organizations
AtaCor Medical
AtaCor Medical is a medical device maker.
Integra LifeSciences
Integra LifeSciences is an integrated medical device company.
LimFlow SA
LimFlow SA is a venture-backed medical device company.
Ossio
Ossio is an orthopedic medical device company.
Sharps Technology
Sharps Technology is an innovative medical device company.
Sonde Health
Sonde Health is a digital medicine company.
Sotera Health
Sotera Health is an integrated global health solutions provider.
Synaptic Medical
Synaptic Medical is a medical device company.
UroMems
UroMems is an innovative medtech company.
Current Employees Featured
Founder
Investors List
VMS Asset Management
VMS Asset Management investment in Series E - SyMap Medical
Sequoia Capital China
Sequoia Capital China investment in Series E - SyMap Medical
Simiao Capital
Simiao Capital investment in Series E - SyMap Medical
Primavera Capital Group
Primavera Capital Group investment in Series E - SyMap Medical
Jisu Capital
Jisu Capital investment in Series D - SyMap Medical
Zheshang Innovest Capital Management
Zheshang Innovest Capital Management investment in Series D - SyMap Medical
Puhua Capital
Puhua Capital investment in Series D - SyMap Medical
Ming Bioventures
Ming Bioventures investment in Series C - SyMap Medical
Kington Capital
Kington Capital investment in Series C - SyMap Medical
Sequoia Capital China
Sequoia Capital China investment in Series B - SyMap Medical
Official Site Inspections
http://www.symapmedical.com
- Host name: 121.40.253.93
- IP address: 121.40.253.93
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "SyMap Medical"
SyMap Medical - Crunchbase Company Profile & Funding
SyMap Medical is an innovative medical device company. ... SyMap is dedicated to developing a proprietary, catheter-based renal mapping and ablation system for renal denervation therapy to treat hypertension and other diseases, such โฆSee details»
่ๅทไฟก่ฟๅป็็งๆ่กไปฝๆ้ๅ ฌๅธ
SyMap ไฟก่ฟๅป็. ๆไธบไปฅๅๆฐๆๆบๅพฎๅไปๅ ฅๆนๆณๆฒป็ๅฟ่ก็ฎกๅๅผๅธ้ขๅ้ๅคง็พ็ ็ๅฝ้ ้ข่ท่ See details»
ๅ ณไบไฟก่ฟ - ่ๅทไฟก่ฟๅป็็งๆ่กไปฝๆ้ๅ ฌๅธ
่ๅทไฟก่ฟๅป็็งๆ่กไปฝๆ้ๅ ฌๅธSee details»
SyMap Medical - Craft
Feb 23, 2022 SyMap Medical $111.02 m in total funding,. See insights on SyMap Medical including office locations, competitors, revenue, financials, executives, subsidiaries and more โฆSee details»
SyMap Medical - PitchBook
SyMap Medical General Information Description. Developer and manufacturer of medical device designed for hypertension, heart failure, severe asthma, refractory complex arrhythmia and โฆSee details»
SyMap Medical - Overview, News & Similar companies - ZoomInfo
View SyMap Medical (www.symapmedical.com) location in China , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
SyMap Medical: Drug pipelines, Patents, Clinical trials - Synapse
Explore SyMap Medical with its drug pipeline, therapeutic area, technology platform, .See details»
SyMap Medical Ltd. Closes Largest Financing Round in Renal โฆ
SUZHOU, China, Dec. 7, 2021 /PRNewswire/ -- SyMap Medical (SyMap) announced its latest financing round of nearly $100 million led by Primavera Capital and VMS Group, with the โฆSee details»
ๅ ฌๅธๆฐ้ป - ่ๅทไฟก่ฟๅป็็งๆ่กไปฝๆ้ๅ ฌๅธ
่ๅทไฟก่ฟๅป็็งๆ่กไปฝๆ้ๅ ฌๅธSee details»
SyMap Medical - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โฆSee details»
SyMap Medical Ltd. Closes Largest Financing Round in Renal โฆ
Dec 7, 2021 As the world's largest financing round in the renal denervation (RDN) field to date, the funds will be used to accelerate global clinical trials for SyMap's disruptive products, โฆSee details»
SyMap Medical Ltd. Announces its Strategic Collaboration with ...
SUZHOU, China, Dec. 29, 2021 /PRNewswire/ -- SyMap Medical Ltd (SyMap) announced its strategic collaboration with Pythagoras Medical. With this win-win collaboration, SyMap has โฆSee details»
SyMap Medical Ltd Completed Enrollment in SMART Study for the โฆ
SUZHOU, China, Feb. 23, 2022 /PRNewswire/ -- SyMap Medical Ltd. (Suzhou, China) announced successful completion of enrollment in the company's SMART Study (Sympathetic โฆSee details»
China's SyMap Medical announces NMPA approval for selective โฆ
Aug 12, 2024 China-based SyMap Medical Ltd announced the approval of its msRDN System (SyMapCath I/ SYMPIONEER S1 by the National Medical Products Administration (NMPA) of โฆSee details»
SyMap Medical Closes Financing to Support Clinical Trials
December 7, 2021โSyMap Medical announced the closing of a financing round of approximately $100 million. SyMap is a China-based company focused on developing device-based โฆSee details»
SyMap Targets Renal Denervation With a Unique Map-and-Ablate โฆ
SUZHOU, China, March 16, 2022 /PRNewswire/ -- SyMap Medical is developing a selective map-and-ablate technology that has the potential to substantially improve outcomes following renal โฆSee details»
SyMap Medical Ltd Completed Enrollment in SMART Study for the โฆ
SUZHOU, China, Feb. 23, 2022 /PRNewswire/ -- SyMap Medical Ltd Completed Enrollment in SMART Study for the Treatment of Uncontrolled HypertensionSee details»
SyMap Medical Ltd Completed Enrollment in SMART Study for the โฆ
SUZHOU, China, Feb. 23, 2022 /PRNewswire/ -- SyMap Medical Ltd. (Suzhou, China) announced successful completion of enrollment in the company's SMART Study (Sympathetic โฆSee details»
SyMap Targets Renal Denervation With a Unique Map-and-Ablate โฆ
SUZHOU, China, March 16, 2022 /PRNewswire/ -- SyMap Medical is developing a selective map-and-ablate technology that has the potential to substantially improve outcomes following renal โฆSee details»